- Country: Uruguay
- Summary: Purchases for Salto Hospital Pharmacy: 1) Linagliptin 5Mg. 2) Acyclovir 5% Topical Skin. 3) Chlorprothixene Ampoules.4) Lmwh40mg *Only Offers with Immediate Delivery are Accepted*
- UYT Ref No: 93556102
- Deadline: 15 Dec 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: Compra Directa 1453/2023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Purchases for Salto Hospital Pharmacy: 1) Linagliptin 5mg. 2) Acyclovir 5% topical skin. 3) Chlorprothixene ampoules.4) LMWH40MG *Only offers with immediate delivery are accepted*
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchases for Salto Hospital Pharmacy: 1) Linagliptin 5Mg. 2) Acyclovir 5% Topical Skin. 3) Chlorprothixene Ampoules.4) Lmwh40mg *Only Offers with Immediate Delivery are Accepted* - Uruguay Tender
The STATE HEALTH SERVICES ADMINISTRATION | DEPARTMENTAL CENTER OF SALTO, a Government sector organization in Uruguay, has announced a new tender for Purchases for Salto Hospital Pharmacy: 1) Linagliptin 5Mg. 2) Acyclovir 5% Topical Skin. 3) Chlorprothixene Ampoules.4) Lmwh40mg *Only Offers with Immediate Delivery are Accepted*. This tender is published on UruguayTenders under UYT Ref No: 93556102 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-12-15.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
